Truvestments Capital LLC - AKARI THERAPEUTICS PLC ownership

AKARI THERAPEUTICS PLC's ticker is AKTX and the CUSIP is 00972G108. A total of 12 filers reported holding AKARI THERAPEUTICS PLC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Truvestments Capital LLC ownership history of AKARI THERAPEUTICS PLC
ValueSharesWeighting
Q2 2023$171
-6.6%
1,0050.0%0.00%
Q1 2023$183
-61.2%
1,0050.0%0.00%
Q4 2022$472
-52.8%
1,005
-38.0%
0.00%
-100.0%
Q3 2022$1,000
-50.0%
1,6210.0%0.00%0.0%
Q2 2022$2,0000.0%1,6210.0%0.00%0.0%
Q4 2021$2,000
-33.3%
1,6210.0%0.00%
-50.0%
Q3 2021$3,0000.0%1,6210.0%0.00%0.0%
Q2 2021$3,000
-25.0%
1,6210.0%0.00%0.0%
Q1 2021$4,000
+33.3%
1,621
-24.4%
0.00%0.0%
Q4 2020$3,000
-25.0%
2,1450.0%0.00%
-50.0%
Q2 2020$4,000
-33.3%
2,145
-41.0%
0.00%0.0%
Q3 2019$6,000
-25.0%
3,633
-8.1%
0.00%
-20.0%
Q2 2019$8,000
-42.9%
3,9520.0%0.01%
-54.5%
Q1 2019$14,000
+27.3%
3,952
-4.1%
0.01%
+120.0%
Q3 2018$11,0004,1220.01%
Other shareholders
AKARI THERAPEUTICS PLC shareholders Q4 2021
NameSharesValueWeighting ↓
SABBY MANAGEMENT, LLC 178,091$703,4590.52%
View complete list of AKARI THERAPEUTICS PLC shareholders